{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:10:32Z","timestamp":1792098632166,"version":"4.4.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"am","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.chest.2021.06.079","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T18:36:08Z","timestamp":1626892568000},"page":"284-287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Tyrosine Kinase Inhibitors for Acute Respiratory Failure Because of Non\u2013small-Cell Lung Cancer Involvement in the ICU"],"prefix":"10.1016","volume":"161","author":[{"given":"Yacine","family":"Tandjaoui-Lambiotte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanis","family":"Akrour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Gibelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle","family":"Stoclin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Jaubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Oppenheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Duchemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Gaudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.chest.2021.06.079_bib1","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.chest.2021.06.079_bib2","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.lungcan.2015.05.009","article-title":"Lung cancer at the intensive care unit: the era of targeted therapy","volume":"89","author":"Adam","year":"2015","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.chest.2021.06.079_bib3","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13613-018-0426-2","article-title":"Characteristics and outcome of patients with newly diagnosed advanced or metastatic lung cancer admitted to intensive care units (ICUs)","volume":"8","author":"Barth","year":"2018","journal-title":"Ann Intensive Care"},{"issue":"10125","key":"10.1016\/j.chest.2021.06.079_bib4","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.chest.2021.06.079_bib5","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.cllc.2016.04.004","article-title":"Treatment of lung cancer patients with actionable mutations in the intensive care unit","volume":"17","author":"Kerrigan","year":"2016","journal-title":"Clin Lung Cancer"},{"issue":"10","key":"10.1016\/j.chest.2021.06.079_bib6","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1007\/s00134-019-05607-z","article-title":"Spectacular improvement of lung computer tomography after treatment with EGFR tyrosine kinase inhibitor for miliary carcinomatosis","volume":"45","author":"Archer","year":"2019","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1016\/j.chest.2021.06.079_bib7","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1200\/JCO.2008.18.7658","article-title":"First-line gefitinib for patients with advanced non\u2013small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy","volume":"27","author":"Inoue","year":"2009","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.chest.2021.06.079_bib8","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1200\/JCO.2008.20.4859","article-title":"The \u201cLazarus Response\u201d in treatment-na\u00efve, poor performance status patients with non-small-cell lung cancer and epidermal growth factor receptor mutation","volume":"27","author":"Langer","year":"2009","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.chest.2021.06.079_bib9","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.7150\/jca.18178","article-title":"Outcomes of cancer therapy administered to treatment-na\u00efve lung cancer patients in the intensive care unit","volume":"8","author":"Chen","year":"2017","journal-title":"J Cancer"},{"issue":"5","key":"10.1016\/j.chest.2021.06.079_bib10","doi-asserted-by":"crossref","first-page":"1602189","DOI":"10.1183\/13993003.02189-2016","article-title":"Intensive care in thoracic oncology","volume":"49","author":"Meert","year":"2017","journal-title":"Eur Respir J"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369221013581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369221013581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:44:50Z","timestamp":1757925890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369221013581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0012369221013581"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2021.06.079","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tyrosine Kinase Inhibitors for Acute Respiratory Failure Because of Non\u2013small-Cell Lung Cancer Involvement in the ICU","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2021.06.079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}